Agenus shifts to BOT+BAL in neoadjuvant MSS colon cancer; $85M raise extends runway to 2031. Click here to read this latest ...
The human gut harbors a vast and dynamic microbial ecosystem that extends far beyond its traditional role in digestion. Over the past decade, mounting ...
A new study published in the Journal of Medicinal Chemistry suggests that a novel vaccine candidate can protect against ...
Q32 Bio Inc. , ("Q32 Bio") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced ...
Harlan Robins liquidated 386,240 shares under a pre-scheduled Rule 10b5-1 trading plan, retaining over 1 million shares worth ...
Martha Stewart on MSN
What eating eggs every day does to your body
While eggs have a place in a balanced diet, there are some things to keep in mind.
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, ...
UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.
A comprehensive review led by Professors Malgorzata Kloc and Xian Chang Li at the Immunobiology and Transplant Science Center ...
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...
The event is for both able-bodied golfers and amputees, according to the Amputee Association of Maine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results